{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:01:30Z","timestamp":1780048890627,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Shanxi Natural Science Foundation of China","award":["NO.202203021222391"],"award-info":[{"award-number":["NO.202203021222391"]}]},{"name":"Shanxi BethuneTalent Foundation Project","award":["No.2021RC038"],"award-info":[{"award-number":["No.2021RC038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51665-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:35:46Z","timestamp":1779442546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The miR4261\/PAMM axis in multiple myeloma promotes bone resorption"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiangxia","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanghui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"12","key":"51665_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Global Burden of Disease","year":"2019","unstructured":"Global Burden of Disease et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global Burden of disease study. JAMA Oncol. 5 (12), 1749\u20131768 (2019).","journal-title":"JAMA Oncol."},{"key":"51665_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/CGM.S16817","volume":"7","author":"A Hameed","year":"2014","unstructured":"Hameed, A., Brady, J. J., Dowling, P., Clynes, M. & O\u2019Gorman, P. Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis. 7, 33\u201342 (2014).","journal-title":"Cancer Growth Metastasis"},{"issue":"3","key":"51665_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/hematolrep16030051","volume":"16","author":"V Eskelinen","year":"2024","unstructured":"Eskelinen, V. et al. First-line combination with proteasome inhibitor-based treatment and zoledronic acid is effective in reducing later fractures in multiple myeloma irrespective of multiple myeloma bone disease at diagnosis. Hematol. Rep. 16 (3), 529\u2013540 (2024).","journal-title":"Hematol. Rep."},{"issue":"13","key":"51665_CR4","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani, N., Rizzoli, V. & Roodman, G. D. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood 108 (13), 3992\u20133996 (2006).","journal-title":"Blood"},{"issue":"3","key":"51665_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/ejh.12239","volume":"92","author":"A Alegre","year":"2014","unstructured":"Alegre, A., Gironella, M., Bail\u00e9n, A. & Giraldo, P. Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review. Eur. J. Haematol. 92 (3), 181\u2013188 (2014).","journal-title":"Eur. J. Haematol."},{"issue":"3.5","key":"51665_CR6","doi-asserted-by":"publisher","first-page":"CLO25","DOI":"10.6004\/jnccn.2024.7215","volume":"23","author":"H Huang","year":"2025","unstructured":"Huang, H. et al. CLO25-072: A multicenter, randomized, controlled, non-inferiority study of narlumosbart compared with Denosumab in the treatment of bone disease in patients with multiple myeloma. J. Natl. Compr. Canc Netw. 23 (3.5), CLO25\u2013072 (2025).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"7","key":"51665_CR7","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1007\/s12325-020-01395-x","volume":"37","author":"SY Huang","year":"2020","unstructured":"Huang, S. Y. et al. Denosumab versus Zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: An international, double-blind, randomized controlled phase 3 study-Asian subgroup analysis. Adv. Ther. 37 (7), 3404\u20133416 (2020).","journal-title":"Adv. Ther."},{"key":"51665_CR8","doi-asserted-by":"publisher","first-page":"608815","DOI":"10.3389\/fonc.2020.608815","volume":"10","author":"T Chen","year":"2020","unstructured":"Chen, T., Moscvin, M. & Bianchi, G. Exosomes in the pathogenesis and treatment of multiple myeloma in the context of the bone marrow microenvironment. Front. Oncol. 10, 608815 (2020).","journal-title":"Front. Oncol."},{"issue":"11","key":"51665_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","volume":"8","author":"S Faict","year":"2018","unstructured":"Faict, S. et al. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 8 (11), 105 (2018).","journal-title":"Blood Cancer J."},{"key":"51665_CR10","doi-asserted-by":"publisher","first-page":"978755","DOI":"10.3389\/fonc.2022.978755","volume":"12","author":"S Bian","year":"2022","unstructured":"Bian, S. et al. Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma. Front. Oncol. 12, 978755 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"51665_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/ars.2009.2886","volume":"13","author":"Y Xu","year":"2010","unstructured":"Xu, Y. et al. PAMM: a redox regulatory protein that modulates osteoclast differentiation. Antioxid. Redox Signal. 13 (1), 27\u201337 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"51665_CR12","doi-asserted-by":"publisher","first-page":"149676","DOI":"10.1016\/j.gene.2025.149676","volume":"965","author":"W Li","year":"2025","unstructured":"Li, W. et al. Oxidative stress-related gene PRXL2A may participate in the occurrence and development of steroid-induced osteonecrosis of the femoral head by regulating osteoclast differentiation: A multi-omics analysis. Gene 965, 149676 (2025).","journal-title":"Gene"},{"key":"51665_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.redox.2015.09.008","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu, Y., Morse, L. R., da Silva, R. A. B., Wang, D. & Battaglino, R. A. A short report: PAMM, a novel antioxidant protein, induced by oxidative stress. Redox Biol. 6, 446\u2013453 (2015).","journal-title":"Redox Biol."},{"key":"51665_CR14","doi-asserted-by":"publisher","first-page":"117789","DOI":"10.1016\/j.bone.2026.117789","volume":"205","author":"J Wang","year":"2026","unstructured":"Wang, J., Zweegman, S. & Groen, R. W. J. Models of myeloma bone disease: In vivo and in vitro approaches. Bone 205, 117789 (2026).","journal-title":"Bone"},{"issue":"12","key":"51665_CR15","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.3390\/ijms22126208","volume":"22","author":"SKR Mukkamalla","year":"2021","unstructured":"Mukkamalla, S. K. R. & Malipeddi, D. Myeloma bone disease: A comprehensive review. Int. J. Mol. Sci. 22 (12), 6208 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"51665_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10238-025-02015-0","volume":"26","author":"MH Safari","year":"2026","unstructured":"Safari, M. H. et al. Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications. Clin. Exp. Med. 26 (1), 114 (2026).","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"51665_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41408-025-01362-1","volume":"15","author":"S Maleknia","year":"2025","unstructured":"Maleknia, S. et al. Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progression. Blood Cancer J. 15 (1), 162 (2025).","journal-title":"Blood Cancer J."},{"issue":"1","key":"51665_CR18","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-021-25473-y","volume":"12","author":"K Wu","year":"2021","unstructured":"Wu, K. et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat. Commun. 12 (1), 5196 (2021).","journal-title":"Nat. Commun."},{"issue":"7","key":"51665_CR19","doi-asserted-by":"publisher","first-page":"151790","DOI":"10.1016\/j.acthis.2021.151790","volume":"123","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Shen, X., Chen, Y., Chen, J. & Li, Y. Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p\/Hpse axis. Acta Histochem. 123 (7), 151790 (2021).","journal-title":"Acta Histochem."},{"issue":"7","key":"51665_CR20","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/cells12071030","volume":"12","author":"SD Alipoor","year":"2023","unstructured":"Alipoor, S. D. & Chang, H. Exosomal miRNAs in the tumor microenvironment of multiple myeloma. Cells 12 (7), 1030 (2023).","journal-title":"Cells"},{"issue":"1","key":"51665_CR21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/21691401.2019.1602538","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J., Li, T. F., Han, X. W. & Yuan, H. F. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt\/\u03b2-catenin signalling. Artif. Cells Nanomed. Biotechnol. 47 (1), 1513\u20131523 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"51665_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.omtn.2017.05.010","volume":"8","author":"G Jiao","year":"2017","unstructured":"Jiao, G. et al. Therapeutic suppression of miR-4261 attenuates colorectal cancer by targeting MCC. Mol. Ther. Nucleic Acids. 8, 36\u201345 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"51665_CR23","doi-asserted-by":"publisher","first-page":"651161","DOI":"10.3389\/fcell.2021.651161","volume":"9","author":"K Inoue","year":"2021","unstructured":"Inoue, K., Ng, C., Xia, Y. & Zhao, B. Regulation of osteoclastogenesis and bone resorption by miRNAs. Front. Cell. Dev. Biol. 9, 651161 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"51665_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/iub.2211","volume":"72","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh, M. H. et al. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis. IUBMB Life. 72 (3), 314\u2013333 (2020).","journal-title":"IUBMB Life"},{"issue":"2","key":"51665_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbrc.2020.02.058","volume":"525","author":"N Gong","year":"2020","unstructured":"Gong, N. et al. Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma. Biochem. Biophys. Res Commun. 525 (2), 341\u2013347 (2020).","journal-title":"Biochem. Biophys. Res Commun"},{"issue":"3","key":"51665_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/BJ20150019","volume":"472","author":"F Guo","year":"2015","unstructured":"Guo, F. et al. Adipocyte-derived PAMM suppresses macrophage inflammation by inhibiting MAPK signalling. Biochem. J. 472 (3), 309\u2013318 (2015).","journal-title":"Biochem. J."},{"issue":"2","key":"51665_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/ijms27020641","volume":"27","author":"KI Lee","year":"2026","unstructured":"Lee, K. I., Chen, J. H. & Chen, K. H. Osteoporosis after menopause and after drug therapy: The molecular mechanism of bone loss and its treatment. Int. J. Mol. Sci. 27 (2), 641 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"51665_CR28","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.2147\/JIR.S563253","volume":"18","author":"P Wen","year":"2025","unstructured":"Wen, P. & Liu, L. Functions of macrophages, T cells, and neutrophils in the synovial microenvironment of osteoarthritis. J. Inflamm. Res. 18, 15671\u201315686 (2025).","journal-title":"J. Inflamm. Res."},{"key":"51665_CR29","doi-asserted-by":"publisher","first-page":"721252","DOI":"10.3389\/fgene.2021.721252","volume":"12","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Antioxidant gene signature impacts the immune infiltration and predicts the prognosis of kidney renal clear cell carcinoma. Front. Genet. 12, 721252 (2021).","journal-title":"Front. Genet."},{"issue":"9","key":"51665_CR30","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/antiox10091435","volume":"10","author":"V Jaiswal","year":"2021","unstructured":"Jaiswal, V., Park, M. & Lee, H. J. Comparative transcriptome analysis of the expression of antioxidant and immunity genes in the spleen of a cyanidin 3-O-glucoside-treated Alzheimer\u2019s mouse model. Antioxid. (Basel). 10 (9), 1435 (2021).","journal-title":"Antioxid. (Basel)"},{"issue":"3","key":"51665_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hon.2728","volume":"38","author":"CK Oh","year":"2020","unstructured":"Oh, C. K. et al. FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis. Hematol. Oncol. 38 (3), 381\u2013389 (2020).","journal-title":"Hematol. Oncol."},{"issue":"4","key":"51665_CR32","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3324\/haematol.2024.286484","volume":"110","author":"A Anloague","year":"2025","unstructured":"Anloague, A. et al. A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma. Haematologica 110 (4), 952\u2013966 (2025).","journal-title":"Haematologica"},{"key":"51665_CR33","doi-asserted-by":"publisher","first-page":"100668","DOI":"10.1016\/j.jbo.2025.100668","volume":"51","author":"O Lungu","year":"2025","unstructured":"Lungu, O., Toscani, D. & Giuliani, N. Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives. J. Bone Oncol. 51, 100668 (2025).","journal-title":"J. Bone Oncol."},{"issue":"7","key":"51665_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-19-0852","volume":"18","author":"T Yu","year":"2020","unstructured":"Yu, T. et al. Polycomb-like protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a. Mol. Cancer Res. 18 (7), 1063\u20131073 (2020).","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"51665_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2011.09.003","volume":"221","author":"Z Qin","year":"2012","unstructured":"Qin, Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221 (1), 2\u201311 (2012).","journal-title":"Atherosclerosis"},{"key":"51665_CR36","doi-asserted-by":"publisher","first-page":"e20230162","DOI":"10.1590\/1678-7757-2023-0162","volume":"31","author":"Y DU","year":"2023","unstructured":"DU, Y. et al. TIPE2 regulates periodontal inflammation by inhibiting NF-\u03baB p65 phosphorylation. J. Appl. Oral Sci. 31, e20230162 (2023).","journal-title":"J. Appl. Oral Sci."},{"key":"51665_CR37","doi-asserted-by":"publisher","first-page":"1647800","DOI":"10.3389\/fendo.2025.1647800","volume":"16","author":"F Salamanna","year":"2025","unstructured":"Salamanna, F. et al. Sustainable innovation with a method based on peripheral mononuclear cells to screen, monitor and stratify the population at risk of osteoporosis and fractures - a multicenter cross-sectional trial protocol. Front. Endocrinol. (Lausanne). 16, 1647800 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"51665_CR38","doi-asserted-by":"publisher","first-page":"e2207877","DOI":"10.1002\/adma.202207877","volume":"35","author":"FE Freeman","year":"2023","unstructured":"Freeman, F. E. et al. Localized nanoparticle-mediated delivery of miR-29b normalizes the dysregulation of bone homeostasis caused by osteosarcoma whilst simultaneously inhibiting tumor growth. Adv. Mater. 35 (23), e2207877 (2023).","journal-title":"Adv. Mater."},{"issue":"6","key":"51665_CR39","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.3892\/mmr.2017.7625","volume":"16","author":"ZH Li","year":"2017","unstructured":"Li, Z. H. et al. High-dose PMA with RANKL and MCSF induces THP 1 cell differentiation into human functional osteoclasts in vitro. Mol. Med. Rep. 16 (6), 8380\u20138384 (2017).","journal-title":"Mol. Med. Rep."},{"key":"51665_CR40","doi-asserted-by":"publisher","first-page":"154967","DOI":"10.1016\/j.phymed.2023.154967","volume":"118","author":"H Yao","year":"2023","unstructured":"Yao, H. et al. Guizhi Shaoyao Zhimu granules attenuate bone destruction in mice with collagen-induced arthritis by promoting mitophagy of osteoclast precursors to inhibit osteoclastogenesis. Phytomedicine 118, 154967. (2023).","journal-title":"Phytomedicine"},{"issue":"1","key":"51665_CR41","doi-asserted-by":"publisher","first-page":"15900","DOI":"10.1038\/s41598-022-19438-4","volume":"12","author":"A Norton","year":"2022","unstructured":"Norton, A., Thieu, K., Baumann, C. W., Lowe, D. A. & Mansky, K. C. Estrogen regulation of myokines that enhance osteoclast differentiation and activity. Sci. Rep. 12 (1), 15900 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51665-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:02:32Z","timestamp":1780045352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51665-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51665-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16693"}}